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With a few exceptions, emerging diseases in
Australia are similar to those in other
industrialized countries (1-8). Most exceptions
are either vector-borne or zoonotic viral diseases,
the major focus of this update. The continuing
emergence of antibiotic resistance is a worldwide
problem. In Australia, antibiotic resistance is
being reported from a growing number of
organisms (9-15), often necessitating new case
management practices and guidelines (16,17).
Also, like other countries, Australia has had a
number of foodborne (18-22) and waterborne (23-
25) epidemics in the past few years; the major
difference is that the higher incidence of
enterohemorrhagic  Escherichia coli linked to
outbreaks of hemolytic uremic syndrome is
associated with serotype O111:H- rather than
serotype O157:H-, which is more common in
other countries. Major waterborne epidemics or
contamination of reservoirs due to Cryptosporidium
parvum have occurred over the past 3 years in the
Eastern States of Australia (23-25), with the
largest and most recent being a problem of
contamination (in association with Giardia
lamblia) in the Sydney water supply between
July and September, 1998. However, despite this
contamination, no increases in the number of
cases of diarrheal disease were reported, perhaps
because the inhabitants of Sydney were advised
to boil the water before drinking it (25).
The distribution and incidence of most of the
recently described viral diseases (e.g., human
herpesviruses 68 and hepatitis C and E viruses)
in Australia are similar to those reported in other
industrialized nations (3). Recent data for
hepatitis G in selected Australian populations
also support this contention (26).
Vector-Borne Viral Diseases
Australia has more than 70 arboviruses, but
relatively few cause human disease (27,28). The
most common arbovirus causing human disease
is Ross River virus, an alphavirus, which causes
an epidemic polyarthritis. Although Ross River
virus incidence has increased over the past
decade, the virus is not emerging; its increased
incidence is probably due to increased awareness
and recognition by general practitioners,
improved diagnostic reagents, and increasing
encroachment of human habitation into or near
wetlands and other areas conducive to mosquito
breeding. The only indigenous virus that can be
called emerging is Barmah Forest virus, also
an alphavirus and also the cause of an epidemic
polyarthritis-like disease. Associated with hu-
man disease only since 1988 and increasing in
incidence as diagnostic reagents have become
available and clinicians have become aware of it,
the virus has spread into new geographic areas,
such as Western Australia (29,30). The two
mosquito-borne diseases of particular concern,
however, are importsJapanese encephalitis
(JE) and dengue viruses.
Japanese Encephalitis Virus
The first outbreak of JE in the Australian
region occurred in Torres Strait, northern
Australia, in 1995 (31). Three cases (two of which
were fatal) were reported from Badu Island in
central Torres Strait, 2,000 km from the nearest
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focus of JE virus activity in Bali.
Seroepidemiologic studies showed that the virus
was relatively widespread in the central and
northern islands with subclinical human cases
on four islands and seropositive pigs on nine
islands. Ten virus isolates were obtained during
the outbreak: two from subclinical human
infections (31) and eight from Culex annulirostris
mosquitoes collected on Badu Island (32).
Sequencing studies showed that these isolates
(most closely related to a 1970 isolate from Kuala
Lumpur and a 1981 isolate from Bali) (33) were
almost identical, suggesting that the outbreak
originated from a single source. These studies
also showed that all isolates had the same 11
nucleotide deletion in the 3' untranslated region
immediately downstream from the stop codon of
the open reading frame (34), which provided a
signature for comparing any future isolates.
After the Badu Island outbreak, inactivated
vaccine was offered to all the inhabitants of the
northern and central Torres Strait islands (35).
During 1996 and 1997, JE virus activity was
detected through seroconversions in sentinel pigs
on Saibai Island, which is in the north and only
about 4 km from the Papua New Guinea coast (36)
(J. Lee, D. Phillips, J. Hanna, unpub. results).
Seroepidemiologic studies found that virus
activity has been widespread in Western
Province, Papua New Guinea, since at least
1989, with seropositivity rates of 21% at that
time among the Daru-speaking people. Results
also showed that seropositivity rates were
increasing in the Upper Fly River area and that
the virus was spreading geographically (37).
Indeed, recent results indicate that JE may have
spread to Vanimo on the northern coast by April
1998 and to parts of Milne Bay Province in
eastern Papua New Guinea (J. Lee, J. Wangi, P.
Siba, G. Tau, unpub. results). The first four
clinical cases of JE in Papua New Guinea were
observed in 1997 and 1998, with two deaths. All
cases were from the Kiunga area of Western
Province (J. Oakley, S. Flew, C.A. Johansen, D.
Phillips, R.A. Hall, J.S. Mackenzie, unpub.
results). Anecdotal evidence suggests that the
cases may have resulted in part from the large
mosquito numbers associated with the severe
drought in 1997. The first JE virus strain
isolated in Papua New Guinea was obtained from
Cx. annulirostris mosquitoes collected at Lake
Murray in Western Province in 1997. Sequence
studies have shown that this isolate was almost
identical to the 1995 Torres Strait isolates,
including the acquisition of the 11 nucleotide
deletion (C.A. Johansen, R. Paru, S.A. Ritchie, A.
Van den Hurk, M. Bockarie, J.S. Mackenzie,
unpub. results).
A second outbreak of JE occurred in Torres
Strait in March 1998, with one human case from
Badu Island and sentinel pigs seroconverting on
a number of islands. Shortly afterwards, the first
human case on mainland Australia was reported
in a fisherman who acquired the infection near
the mouth of the Mitchell River in southwest
Cape York (38). Extensive seroepidemiologic
investigations found no further human infec-
tions in communities on Cape York, but domestic
pigs had seroconverted both near Mitchell River
and near Bamega at the northerly tip of Cape
York. Two virus isolations were obtained from
pig sera collected near Bamega, and one isolate
was obtained from a sentinel pig on Mabuiag
Island in Torres Strait (J. Hanna, S. Hills, D.
Phillips, J. Lee, unpub. results). Mosquitoes
were collected at a number of sites on Cape York
as well as on Badu Island. No viruses were
isolated from the Cape York mosquitoes, but
approximately 44 isolates were obtained from
Badu Island43 from Cx. annulirostris mosqui-
toes and one from Aedes vigilax mosquitoes (S.A.
Ritchie, A. Van Den Hurk, C.A. Johansen, D.
Phillips, A. Pyke, J.S. Mackenzie, unpub.
results). Nucleotide sequencing studies have
shown that the mosquito and pig isolates from
Mabuiag and Cape York were closely related to
each other, as well as to the 1997 Papua New
Guinea Lake Murray and the 1995 Badu Island
isolates, including all isolates sharing the 11
base signature deletion, which indicated a
single virus source for the virus activity in
Northern Australia and Papua New Guinea. The
focus of activity is probably in Papua New
Guinea (C.A. Johansen, A. Drew, D.A. Phillips,
A. Pyke, J.S. Mackenzie, unpub. results).
JE virus activity in northern Australia began
in 1998. Sentinel animal sites are being
established to investigate whether the virus has
become enzootic in the wildlife. Australia has
both the mosquito vectors (Cx. annulirostris) and
vertebrate hosts (ardeid birds and pigs) for the
virus to become established. In addition, large
areas of wetland habitats in Cape York would be
conducive to virus enzootic cycles and would
increase the potential for the virus to move south
to more populous areas of Australia (39).3 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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Dengue Viruses
Despite a 120-year history, dengue does not
appear to be endemic in Australia. Several
epidemics over the past decade have been initiated
from virus introduced by viremic travelers
(27,28,40). Imported cases of dengue in travelers
are regularly diagnosed throughout Australia,
with 30 to 60 cases reported annually, and
growing in number. In most parts of Australia
where the local mosquitoes are unable to
transmit dengue viruses, these cases pose no
risk, but in areas of north Queensland where
Ae. aegypti is common and travel between
Australia  and countries in the Asian-Pacific area is
frequent, local transmission and epidemic activity
are major risks. The potential for local
transmission of dengue viruses is confined to an
area of Queensland corresponding to the
geographic range of Ae. aegypti, extending from
the islands of Torres Strait in the north, to
Mount Isa and Boulia in the west, possibly to
Roma in the south, and to Gladstone on the east
coast (41). Despite this relatively broad geographic
range, epidemic activity over the past 2 decades
has been restricted from Torres Strait south to
Cairns, Townsville, and Charters Towers. The
major epidemics over the past 5 years have
included a large outbreak of dengue type 2 in 1992
to 1993, principally in Townsville and Charters
Towers with more than 2,000 cases, and with the
first case of dengue hemorrhagic fever this
century (42,43); an outbreak of dengue type 2 in
1996 to 1997 on a number of Torres Strait islands
and Cairns, with more than 200 serologically
confirmed cases (44,45); and an outbreak of dengue
type 3 in 1997 to 1998 largely restricted to Cairns
with 239 confirmed cases (46; S. Ritchie, S. Hills,
pers. comm.) and also a few cases of dengue type
2. This latter outbreak also included a case of
dengue hemorrhagic fever and the first case of
dengue encephalopathy in Australia (J. Hanna,
unpub. obs.). Nucleotide sequencing of dengue 2
isolates from Australia and a comparison with
isolates from elsewhere in the Asian-Pacific region
indicated that the 1992-93 isolates were most
closely related to an Indonesian virus, whereas
the 1996-97 isolates were most closely related
to viruses originally isolated in Burkina Faso.
This latter finding is of interest because a large
outbreak of dengue type 2 occurred on a number
of Pacific Islands before and during the Australian
outbreak, but the South Pacific viruses were quite
distinct from the Australian viruses (45).
After the 1992-93 outbreak, a Dengue Fever
Management Plan was developed to reduce the
potential for epidemic activity from imported
cases. The plan has been extremely successful,
and a number of imported cases have been
recognized early and were contained before they
could cause an epidemic (47,48). However,
importation, either by continual movement of
people between Papua New Guinea and Torres
Strait or by movement of people for work,
education, or recreation between Papua New
Guinea and north Queensland, will always be a
major route of entry of the virus.
Vector importations occur frequently, with a
number of reports for both Ae. aegypti and
Ae. albopictus (27), including two recent importa-
tions of Ae. albopictus into Townsville in 1997
(49) and Cairns in 1998 (S. Ritchie, pers. comm.).
Novel Zoonotic Viral Diseases
In the past 4 years, three newly described
zoonotic viral diseases have been reported from
Australia; two of these diseases are caused by the
paramyxoviruses Menangle and Hendra (for-
merly equine morbillivirus), and the third is
caused by Australian bat lyssavirus.
Menangle Virus
An apparently new virus in the family
Paramyxoviridae was isolated from stillborn
piglets with deformities at a large commercial
piggery in New South Wales (51). The farrowing
rate in the piggery decreased from an expected
82% to 60%; the number of live piglets declined in
27% of the litters born; the proportion of
mummified and stillborn piglets, some with
deformities, increased; and occasional abortions
occurred. Virus was isolated from lung, brain,
and heart tissues of infected piglets, and shown
to be morphologically similar to viruses in the
family Paramyxoviridae. No disease was seen in
postnatal animals of any age, but a high
proportion of sera (>90%) from animals of all ages
contained high titers of neutralizing antibodies
against the virus. Tests performed at the
Australian Animal Health Laboratory confirmed
that the virus, named Menangle virus, was
unrelated to other known paramyxoviruses,
including viruses known to infect pigs (51).
Serum from two workersone at the
affected piggery and one at an associated piggery
that had received weaned pigs from the original
piggeryhad high titer, convalescent-phase4 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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neutralizing antibodies to the new virus. Both
workers had an influenzalike illness with rash
during the pig outbreak, but extensive serologic
testing showed no evidence of any alternative
cause; therefore, the illness is believed to have
been caused by the new virus (52).
A large breeding colony of gray-headed and
little red fruit bats roosted within 200 m of the
affected piggery. In a preliminary study, 42 of
125 serum samples collected from fruit bats in
New South Wales and Queensland had
neutralizing antibodies to the new virus. In
addition, antibodies were found in sera collected
in 1996, before the outbreak, and from a colony of
fruit bats 33 km from the piggery (51). Therefore,
the fruit bats are believed to be the primary
source of virus causing the outbreak. Sera
collected from wild and domestic animals near
the affected piggery were seronegative.
The geographic range, normal host species,
and genetic relationship of this new virus to
other paramyxoviruses remain unknown. Never-
theless, Menangle appears to cause fatal disease
and malformations in prenatal pigs and may be
associated with influenzalike illness in humans.
Hendra Virus
Hendra virus was first recognized in 1994
after an explosive outbreak of severe, fatal
respiratory disease affecting race horses and
humans. Twenty race horses in the Brisbane
suburb of Hendra were infected; 13 died. The
trainer and stable hand were also infected, and
the trainer died (53-55). A second incident
occurred in Mackay, a coastal town approxi-
mately 1,000 km north of Brisbane. Two horses
and a farmer died, the latter from severe
meningoencephalitis (56-58). The death of the
horses and the initial infection of the farmer
occurred in 1994 and preceded the Brisbane
outbreak; the virus is believed to have then
entered a latent phase for 1 year before
reactivating to cause fatal encephalitis. No
connection was found between the Brisbane and
Mackay incidents (56). Experimental studies
have shown that in horses and cats, after
subcutaneous, intranasal, and oral administra-
tion, the virus causes fatal pneumonia (59). In
guinea pigs, subcutaneous administration is also
fatal, but the infection is more generalized. Black
fruit bats (Pteropus alecto) infected by subcuta-
neous, intranasal, or oral routes contract a
subclinical infection and generate an antibody
response (M. Williamson, unpub. results).
Endothelial cell tropism and formation of
syncytia in blood vessels are common pathologic
findings in both overt and subclinical infections
(B.T. Eaton, M. Williamson, unpub. obs.).
Extensive seroepidemiologic studies found
no evidence of Hendra virus among horses, other
farm animals, or more than 40 species of wildlife
in Queensland (56,60; P.L. Young, K. Halpin, H.
Field, unpub. results). However, working on the
hypothesis that if outbreaks at two distant sites
were connected, the most likely wildlife source
would be either birds or fruit bats, P.L. Young
and colleagues subsequently showed that fruit
bats (flying foxes), members of Megachiroptera,
were the natural hosts on serologic grounds and
by virus isolation, with widespread evidence of
infection in four species of fruit bat: the black
(Pteropus alecto), grey-headed (P. poliocephalus),
little red (P. scapulatus), and spectacled
(P. conspicillatus) fruit bats (61,62; P.L. Young
et al., unpub. results). Indeed the virus was
antigenically and genetically indistinguishable
from the earlier horse and human isolates. Thus,
it is now clearly established that Hendra virus is
a fruit bat virus and is widely distributed
throughout the range of pteropid bats in
Australia, with serologic evidence of infection in
an average of 42% of wild-caught bats, the
number of seropositive animals varying with
species (53% of 229 P. alecto, 47% of 195
P. poliocephalus, 12% of 115 P. scapulatus, and
41% of 99 P. conspicillatus) and age, but not with
geographic distribution (H. Field, unpub. results).
Serologic evidence of infection of fruit bats has
also been reported from Papua New Guinea. Two
species of antibody-positive bats (Dobsonia
moluccense,  P. neohibernicus) were identified from
Madang on the north coast of Papua New Guinea
(K. Halpin, H. Field, J.S. Mackenzie, M. Bockarie,
P.L. Young, P.W. Selleck, unpub. results), and
bats of four more species (D. andersoni, P.
capistratus, P. hypomelanus, and P. admiralitatum)
were identified in Port Moresby and New Britain
(H. Field, S. Hamilton, L. Hall, F. Bornacosso, K.
Halpin, P.L. Young, unpub. results).
Morphologic features (63) and preliminary
sequencing data of the M and F genes (64)
suggested that Hendra virus was a member of
the Paramyxoviridae, although it had unusual
surface projections of two distinct lengths, 15 nm
and 18 nm (63). The entire genome of the virus
has now been sequenced (65;66; L.F. Wang, B.T.5 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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Eaton and colleagues, unpub. results) and has
revealed a gene order and P gene organization
characteristic of members of the Paramyxovirus
and Morbillivirus genera (65). Comparison of its
deduced amino acid sequences with those of
other family members confirm that Hendra virus
is a member of the subfamily Paramyxovirinae,
more closely related to members of the
Paramyxovirus and Morbillivirus genera than
the Rubulavirus genus. Overall, homology with
other members of the subfamily is lower than
that observed within an individual genus (L.F.
Wang, B.T. Eaton, unpub. results). Hendra virus
has several distinguishing features, including a
genome that is 15% larger than that of other
members, with each of the six transcription units
containing a very long 3' untranslated region
(L.F. Wang, B.T. Eaton, unpub. results). The P/
V/C gene has a fourth open reading frame located
between those of the C and V proteins and
potentially encoding a small basic protein similar
to those of some members of the Rhabdoviridae
and Filoviridae; its long 3' untranslated region is
a common feature of the Filoviridae (65). The
sequence of the N gene has also recently been
described (66), and like the P/V/C gene, has a 3'
untranslated region approximately tenfold
longer than other members of the
Paramyxovirinae. Although the deduced amino
acid sequence of the N protein was slightly more
homologous to members of the Morbillivirus
genus than to those of other Paramyxovirinae
genera, the level of identity was much lower than
that observed within the Morbillivirus genus.
Three other findings differentiate Hendra
from most other members of the Paramyxoviri-
dae: the wide host range (59), the cleavage site of
the F protein, and the orientation of the cell
surface from which virus is released (B.T. Eaton,
W. Michalski, and M. Williamson, unpub.
results). An accumulating body of evidencesize
of genome, comparative sequence analyses,
coding capacity for a small basic protein in the P
gene, morphologic features, host range, and
various biologic properties, together with the
wildlife host of the virussuggests that the virus
had been misnamedit was neither an equine
virus nor a morbillivirusalthough the name
was relevant when the virus was first isolated. It
has therefore been suggested that the virus be
renamed Hendra and be classified in a new
genus within the Paramyxovirinae (59,65,66). A
number of aspects of the ecology of the virus
remain to be determined. For instance, despite
the obvious ubiquity of the virus in the fruit bat
population and the extremely close relationship
between bat caregivers and bats, there is no
evidence of seroconversions among caregivers,
despite their close contact with up to 1,000 bats
per year (50). Specimens of persons who have
died of either pneumonia or encephalitis of
unknown etiology were virus-negative (C. Allan,
J.S. Mackenzie, L.A. Selvey, unpub. results).
Furthermore, all human infections appear to
have been transmitted by horses. Thus, the virus
appears to have low transmissibility to humans;
it also appears to be linked with pregnancy: the
index case of the Brisbane outbreak was a
pregnant  mare, a pregnant mare was involved in
the Mackay incident, both incidents occurred
during the birthing season of flying foxes, and
virus was first recovered from uterine fluid of a
pregnant animal (3). Thus, a number of
questions remain about the ecologic, biologic,
and pathologic characteristics of Hendra virus:
1) the infectivity and virulence of the virus and
why it seems extremely difficult to transmit
naturally between and within some susceptible
host species, 2) classification of the virus, 3) role
of pregnancy to transmission of the virus, 4) role
of prior infection in horses in human infection, 5)
method of transmission between fruit bats and
from fruit bats to horses, 6) tropism of the virus,
and 7) potential for producing a latent infection
in humans.
Australian Bat Lyssavirus
Australia had been considered free of rabies
and rabieslike viruses until 1996 when a new
lyssavirus, closely related to classic rabies virus,
was first identified in a fixed brain specimen
from a young black flying fox (P. alecto), with
unusual neurologic symptoms. Since this
original isolation, a further 42 isolates have been
obtained from all four species of fruit bat, with
most isolates from black and little red
(P. scapulatus) flying foxes, and four isolates
from an insectivorous bat (Microchiroptera), the
yellow-bellied sheathtail bat (Saccolaimus
flavicentris) (P. Daniels, R. Lunt, unpub.
results). The isolates were from as far apart as
Melbourne and Darwin, but most were from
Queensland. Antibodies to rabies virus (REFIT
assay) have been detected in 2.6% of 345 bat
nonrandom samples submitted to the Australian
Animal Health Laboratory (P. Daniels, R. Lunt,6 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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unpub. results). Antibody has been detected in
both infected and apparently healthy bats, but
whether this reflects the ability of bats to recover
from infection or become latently infected with
the virus is not known.
Analysis using nucleocapsid-specific mono-
clonal antibodies showed a strong relationship
between this new lyssavirus and serotype 1
rabies virus (67). Indeed, rabies vaccine may
elicit a protective immune response in humans,
indicating the antigenic similarity of Australian
bat lyssavirus and classic rabies virus (P.K.
Murray, pers. comm. to the Lyssavirus Expert
Committee [68]). Phylogenetic studies of the N
protein sequences indicated that the Australian
virus was genetically distinct from classic rabies
(genotype 1) and was, therefore, a previously
unrecognized member of the Lyssavirus genus
and represented a new genotype, genotype 7 (67).
Two human infections have been attributed
to Australian bat lyssavirus. One fatal rabieslike
infection was in a female bat caregiver from
Rockhampton, Queensland (69,70). An isolate of
Australian bat lyssavirus obtained post-mortem
was antigenically and genetically similar to the
virus from the insectivorous yellow-bellied
sheathtail bat (A.R. Gould, R. Lunt, P. Daniels,
unpub. results). A second death has recently
been reported in Queensland (J. Hann, J.
Faoagali, G. Smith, I Serafin, J. Northill, unpub.
obs.). The infection was in a 27-year-old woman
from Mackay, who died 2 years after a bat bite
(by a large flying fox). Polymerase chain reaction
(PCR) testing of RNA extracted from saliva and
nuchal biopsy proved vital to the antemortem
diagnosis. Immunofluorescence staining of
postmortem samples confirmed the diagnosis.
Preliminary sequencing of the amplicon has
indicated that the virus is very similar to other
lyssaviruses isolated from flying foxes but clearly
distinct from a virus isolate from a yellow-bellied
sheathtail bat (I. Serafin, G. Smith, J. Hanna, B.
Harrower, J. Northill, A. Westcott, unpub. obs.).
More extensive sequencing of the human and bat
isolates is under way. Measures to prevent further
human infection have been implemented (68,71).
As with Hendra virus, a number of questions
remain about the ecology and biology of
Australian bat lyssavirus. The finding of well,
antibody-positive bats, which suggests that bats
can either recover from infection or that they can
be silently infected, needs to be investigated,
particularly with respect to infectivity and
possible transmissibility. More information is
needed on the geographic and host range of the
virus ecology within bat communities and risk
for transmission to terrestrial animals.
These novel zoonotic viruses appear to have
frugivorous bats as their natural vertebrate
hosts. While little is known of the viral fauna of
fruit bats (or indeed of most wildlife species) in
Australia, the occurrence of these three zoonotic
viruses from bats over 3 years suggests that
further prospective studies of diseases of wildlife
are warranted. Indeed, two paramyxoviruslike
viruses unrelated to any other known paramyx-
oviruses (K. Halpin, P.L. Young, unpub. results)
have recently been isolated from flying foxes.
Conclusions
The vector-borne and zoonotic diseases in
this editorial encompass three patterns of
emergence: known diseases increasing in
incidence or geographic range (e.g., dengue and
JE virus, respectively); new infectious agents as
etiologic agents of known diseases (e.g.,
Australian bat lyssavirus as a cause of a
rabieslike illness); and new infectious agents
causing previously unrecognized diseases (e.g.,
Hendra virus). All three patterns demonstrate
the need (and international responsibility) for
ongoing surveillance and monitoring. In Austra-
lia, surveillance is the legislative responsibility
of the individual states and territories. A
Communicable Diseases Network Australia-
New Zealand was established in 1989 to improve
the control of communicable diseases in
Australia by coordinating national surveillance
activities and responses to outbreaks and by
training public health staff. In 1996, Australia
developed a National Communicable Diseases
Surveillance Strategy to provide a national
framework to monitor infectious diseases and
plan and prioritize interventions. Components of
the strategy include improvements to the national
surveillance infrastructure, better monitoring of
diseases and surveillance data, and better
response to outbreaks. The strategy is being
implemented and may provide the mechanism for a
national response to new and reemerging diseases.
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